Blood Test Catches Cancers That Shed Little DNA.

A new liquid biopsy test can accurately detect aberrant cancer-associated methylation patterns from minute amounts of DNA shed into the bloodstream. Although prospective validation is still needed, two studies highlight the assay's potential to noninvasively classify brain and kidney tumors.